Israel Englander Galapagos Nv Call Options Transaction History

Millennium Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2023 May 15, 2023	SELL	$36.5 - $48.0 $1.83 Million - $2.4 Million	-50,000 Reduced 62.5%	30,000 $1.16 Million
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $3 Million - $3.72 Million	80,000 New	80,000 $3.55 Million

16.5M

77.1K

57.2K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.63B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.